Company news: Althea; Bod; ECS Botanics; LGP; Live Verdure; Creso Pharma; Emyria; Medlab by Martin Lane February 24, 2022February 24, 2022 Althea Althea chief executive Josh Fegan has described the first half of the 2022 financial year […]
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022February 13, 2023
Company news: ECS Botanics: Zelira; InhaleRx; Emyria; Rua Bioscience; MJBiz by Martin Lane January 13, 2022January 13, 2022
Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021December 22, 2021
Company news: MGC Pharma/Extrax; Epsilon; Auscann; Roots; TSN; Emyria by cannabiz team December 16, 2021December 16, 2021
Emyria raises A$5m to accelerate drug development and registration programs by Martin Lane November 22, 2021November 25, 2021
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021October 21, 2021
Emyria selected to join Palantir’s foundry builders program by Martin Lane October 8, 2021August 14, 2023